News
Elon Musk's Neuralink said on Monday that it had raised $650 million in its latest funding round as its brain implant device ...
1h
News-Medical.Net on MSNNew study stands to improve the rigor and reliability of psychedelic clinical trialsAs psychedelics gain traction as potential treatments for mental health disorders, an international study led by researchers ...
Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...
Nucala's approval offers hope for uncontrolled COPD. This new drug reduces flare-ups, a key benefit for Black Americans.
It would help the trials—and patients—if more people were tested for Alzheimer’s earlier on, so that they could be enrolled ...
The new review of Alzheimer’s disease in clinical trials in 2025 found 182 clinical trials assessing the impact of 138 drugs.
One clinical trial is assessing whether semaglutide, used in weight loss drugs, could slow the progression of dementia ...
In this video interview, Ron Lanton, partner, Lanton Law, talks FDA layoffs and their impact on inspections and clinical ...
16h
Interesting Engineering on MSNNeuralink rival Paradromics completes first human implant, plans clinical trialsParadromics completes first human BCI implant, setting stage for clinical trials targeting severe motor impairment.
There’s been a leap in potential new medicines being tested in clinical trials for Alzheimer’s, according to a new annual ...
Pediatric patients exhibited high risk for severe avian influenza A/H5N1, suggesting clinical therapeutic and vaccine trials should be prioritized in this population.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results